BifidoBiotics Bifido Lacto Blend
On sale on the US market (according to the DSLD)
Allergy Research Group, food supplement from the US market
BifidoBiotics Bifido Lacto Blend (Allergy Research Group), a food supplement au code-barres 713947719101, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Allergy Research Group
- Barcode
- 713947719101
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- up to 3 servings per day
- Other ingredients (in English, as written)
- Hydroxypropyl Methylcellulose, Maltodextrin, Stearic Acid, Silicon Dioxide
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Lactobacillus rhamnosus LR-32 | Plant | not stated |
| Bifidobacterium breve Bb-03 | Micro-organism | not stated |
| Bifidobacterium longum Bl-05 | Micro-organism | not stated |
| Bifidobacterium animalis lactis BL-04 | Micro-organism | not stated |
| Lactobacillus acidophilus LA-14 | Micro-organism | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: BifidoBiotics Bifido Lacto Blend
Entered into DSLD on 18 December 2021. On sale on the US market (according to the DSLD).- Same quantity, different name: Bifidobacterium lactis Bl-04 in this version; Bifidobacterium animalis lactis BL-04 on the displayed label (quantity not stated)
Official label: BifidoBiotics with LactoSpore
Entered into DSLD on 23 October 2019. Withdrawn from the US market on 2 August 2021 (according to the DSLD).- Active ingredient added : Bifidobacterium breve (ATCC SD5206) (quantity not stated)
- Active ingredient added : Bifidobacterium longum (ATCC SD5588) (quantity not stated)
- Active ingredient added : Lactobacillus acidophilus (ATCC SD5212) (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus (ATCC SD5217) (quantity not stated)
- Active ingredient added : LactoSpore (quantity not stated)
- Active ingredient removed : Bifidobacterium animalis lactis BL-04 (quantity not stated)
- Active ingredient removed : Bifidobacterium breve Bb-03 (quantity not stated)
- Active ingredient removed : Bifidobacterium longum Bl-05 (quantity not stated)
- Active ingredient removed : Lactobacillus acidophilus LA-14 (quantity not stated)
- Active ingredient removed : Lactobacillus rhamnosus LR-32 (quantity not stated)
Official label: BifidoBiotics with LactoSpore
Entered into DSLD on 21 November 2018. Withdrawn from the US market on 26 June 2019 (according to the DSLD).- Active ingredient added : Bifidobacterium breve (ATCC SD5206) (quantity not stated)
- Active ingredient added : Bifidobacterium longum (ATCC SD5588) (quantity not stated)
- Active ingredient added : Lactobacillus acidophilus (ATCC SD5212) (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus (ATCC SD5217) (quantity not stated)
- Active ingredient added : LactoSpore (quantity not stated)
- Active ingredient removed : Bifidobacterium animalis lactis BL-04 (quantity not stated)
- Active ingredient removed : Bifidobacterium breve Bb-03 (quantity not stated)
- Active ingredient removed : Bifidobacterium longum Bl-05 (quantity not stated)
- Active ingredient removed : Lactobacillus acidophilus LA-14 (quantity not stated)
- Active ingredient removed : Lactobacillus rhamnosus LR-32 (quantity not stated)
Official label: BifidoBiotics With L. Sporogenes
Entered into DSLD on 23 December 2015. Withdrawn from the US market on 19 July 2018 (according to the DSLD).- Active ingredient added : Bifidobacterium breve (12,000,000,000,000 {Unit(s)})
- Active ingredient added : Bifidobacterium longum (12,000,000,000,000 {Unit(s)})
- Active ingredient added : Lactobacillus acidophilus (24,000,000,000,000 {Unit(s)})
- Active ingredient added : Lactobacillus rhamnosus (22,000,000,000,000 {Unit(s)})
- Active ingredient added : Lactobacillus sporogenes (36,000,000,000,000 {Unit(s)})
- Active ingredient removed : Bifidobacterium animalis lactis BL-04 (quantity not stated)
- Active ingredient removed : Bifidobacterium breve Bb-03 (quantity not stated)
- Active ingredient removed : Bifidobacterium longum Bl-05 (quantity not stated)
- Active ingredient removed : Lactobacillus acidophilus LA-14 (quantity not stated)
- Active ingredient removed : Lactobacillus rhamnosus LR-32 (quantity not stated)
Official label: BifidoBiotics With L. Sporogenes
Entered into DSLD on 25 April 2013. Withdrawn from the US market on 19 November 2015 (according to the DSLD).- Active ingredient added : Bifidobacterium breve (1,200,000,000 Microorganism(s))
- Active ingredient added : Bifidobacterium longum (1,200,000,000 Microorganism(s))
- Active ingredient added : Lactobacillus acidophilus (240,000,000 Microorganism(s))
- Active ingredient added : Lactobacillus rhamnosus (2,200,000,000 Microorganism(s))
- Active ingredient added : Lactobacillus sporogenes (360,000,000 Microorganism(s))
- Active ingredient removed : Bifidobacterium animalis lactis BL-04 (quantity not stated)
- Active ingredient removed : Bifidobacterium breve Bb-03 (quantity not stated)
- Active ingredient removed : Bifidobacterium longum Bl-05 (quantity not stated)
- Active ingredient removed : Lactobacillus acidophilus LA-14 (quantity not stated)
- Active ingredient removed : Lactobacillus rhamnosus LR-32 (quantity not stated)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Allergy Research Group
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “BifidoBiotics Bifido Lacto Blend (Allergy Research Group): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/713947719101-bifidobiotics-bifido-lacto-blend-allergy-research-group, updated 14 December 2023.